NA

Noura S. Abul-Husn

RP Regeneron Pharmaceuticals: 9 patents #133 of 810Top 20%
📍 New York, NY: #2,183 of 20,192 inventorsTop 15%
🗺 New York: #16,265 of 115,490 inventorsTop 15%
Overall (All Time): #535,639 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12359201 17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof Gregory Hinkle, Frederic Tremblay, Omri GOTTESMAN, Alexander Li, Xiping Cheng +6 more 2025-07-15
12286677 Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation Yurong Xin, Jesper Gromada, Xiping Cheng, Frederick Dewey, Tanya Teslovich Dostal +2 more 2025-04-29
11845963 HSD17B13 variants and uses thereof Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin, Jesper Gromada +3 more 2023-12-19
11753628 HSD17B13 variants and uses thereof Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin, Jesper Gromada +3 more 2023-09-12
11702700 Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation Yurong Xin, Jesper Gromada, Xiping Cheng, Frederick Dewey, Tanya Teslovich Dostal +2 more 2023-07-18
11485958 HSD17B13 variants and uses thereof Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin, Evangelos Pefanis +5 more 2022-11-01
11180757 17β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof Gregory Hinkle, Frederic Tremblay, Omri GOTTESMAN, Alexander Li, Xiping Cheng +6 more 2021-11-23
10961583 Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation Yurong Xin, Jesper Gromada, Xiping Cheng, Frederick Dewey, Tanya Teslovich Dostal +2 more 2021-03-30
10787647 HSD17B13 variants and uses thereof Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin, Evangelos Pefanis +5 more 2020-09-29